STOCK TITAN

Scilex (SCLX) CEO Henry Ji buys 3.25M warrants, sells 650K next day

Filing Impact
(Very High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Scilex Holding Co executive Henry Ji reported mixed warrant trades. On April 16, 2026, he made an open-market purchase of 3,250,000 warrants at $0.1538 per warrant, each exercisable at $1.20 for common stock. On April 17, 2026, he sold 650,000 warrants at the same price, leaving 2,600,000 warrants held directly, expiring on June 18, 2029.

Positive

  • None.

Negative

  • None.
Insider Ji Henry
Role Exec Chair, CEO and President
Bought 3,250,000 shs ($500K)
Sold 650,000 shs ($100K)
Type Security Shares Price Value
Sale Warrant (right to buy) 650,000 $0.1538 $100K
Purchase Warrant (right to buy) 3,250,000 $0.1538 $500K
Holdings After Transaction: Warrant (right to buy) — 2,600,000 shares (Direct, null)
Footnotes (1)
Warrants purchased 3,250,000 warrants Open-market purchase on April 16, 2026 at $0.1538
Warrants sold 650,000 warrants Open-market sale on April 17, 2026 at $0.1538
Warrants held after trades 2,600,000 warrants Total derivative holdings following April 17, 2026 sale
Transaction price per warrant $0.1538 per warrant Both purchase and sale prices
Warrant exercise price $1.20 per share Conversion price into Scilex common stock
Warrant expiration date June 18, 2029 Expiration for traded warrants
Warrant (right to buy) financial
"security_title: "Warrant (right to buy)""
open-market purchase financial
"transaction_action: "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
conversion or exercise price financial
"conversion_or_exercise_price: "1.2000""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ji Henry

(Last)(First)(Middle)
C/O SCILEX HOLDING COMPANY
960 SAN ANTONIO ROAD

(Street)
PALO ALTO CALIFORNIA 94303

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Scilex Holding Co [ SCLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Exec Chair, CEO and President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant (right to buy)$1.204/16/2026P3,250,00004/16/202606/18/2029Common Stock3,250,000$0.15383,250,000D
Warrant (right to buy)$1.204/17/2026S650,00004/16/202606/18/2029Common Stock650,000$0.15382,600,000D
Explanation of Responses:
/s/ Stephen Ma, as Attorney-in-Fact04/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Scilex (SCLX) report for Henry Ji?

Henry Ji reported buying and selling Scilex warrants. He purchased 3,250,000 warrants on April 16, 2026, then sold 650,000 warrants on April 17, 2026, both at $0.1538 per warrant, leaving 2,600,000 warrants held directly.

What type of securities did Henry Ji trade in this Scilex (SCLX) Form 4?

The transactions involved warrants, which are rights to buy Scilex common stock. Each warrant is exercisable at $1.20 per share and expires on June 18, 2029, giving Henry Ji long-dated exposure to Scilex equity.

What prices were paid and received in Henry Ji’s Scilex (SCLX) warrant trades?

Both the purchase and sale of warrants occurred at $0.1538 per warrant. Ji bought 3,250,000 warrants and later sold 650,000 warrants at the same $0.1538 price, so the reported transactions show no price difference between buy and sell.

How many Scilex (SCLX) warrants does Henry Ji hold after these transactions?

After the reported trades, Henry Ji directly holds 2,600,000 Scilex warrants. This figure comes from the Form 4 totals, reflecting 3,250,000 warrants bought and 650,000 warrants sold in open-market transactions on consecutive days.

What are the key terms of the Scilex (SCLX) warrants traded by Henry Ji?

The warrants give the right to buy Scilex common stock at an exercise price of $1.20 per share. They were traded around $0.1538 per warrant and carry an expiration date of June 18, 2029, according to the Form 4 disclosure.